• Citer

Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome?

par Bonnefoi, H;Diebold-Berger, S;Therasse, P.;Hamilton, Andrew;Van de Vijver, Marc J;MacGrogan, G;Shepherd, L;Amaral, N;Duval, C;Drijkoningen, R;Larsimont, Denis ;Piccart-Gebhart, Martine
Référence Annals of oncology, 14, 3, page (406-413)
Publication Publié, 2003-03

Article révisé par les pairs

• Détails
• Contenu

Titre:	Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome?
Auteur:	Bonnefoi, H; Diebold-Berger, S; Therasse, P.; Hamilton, Andrew; Van de Vijver, Marc J; MacGrogan, G; Shepherd, L; Amaral, N; Duval, C; Drijkoningen, R; Larsimont, Denis; Piccart-Gebhart, Martine
Informations sur la publication:	Annals of oncology, 14, 3, page (406-413)
Statut de publication:	Publié, 2003-03
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Administration, Oral
	Adult
	Aged
	Anthracyclines -- therapeutic use
	Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Breast Neoplasms -- drug therapy
	Breast Neoplasms -- pathology
	Cyclin D1 -- biosynthesis
	Cyclin D1 -- blood
	Cyclophosphamide -- administration & dosage
	Epirubicin -- administration & dosage
	Female
	Fluorouracil -- administration & dosage
	Gene Expression Regulation, Neoplastic
	Granulocyte Colony-Stimulating Factor -- administration & dosage
	Humans
	Immunohistochemistry
	Infusions, Intravenous
	Ki-67 Antigen -- analysis
	Ki-67 Antigen -- biosynthesis
	Middle Aged
	Neoadjuvant Therapy
	Predictive Value of Tests
	Prognosis
	Receptor, erbB-2 -- biosynthesis
	Receptor, erbB-2 -- blood
	Receptors, Estrogen -- analysis
	Receptors, Estrogen -- biosynthesis
	Receptors, Progesterone -- analysis
	Receptors, Progesterone -- biosynthesis
	Survival Analysis
	Treatment Outcome
	Tumor Markers, Biological -- analysis
	Tumor Suppressor Protein p53 -- biosynthesis
	Tumor Suppressor Protein p53 -- blood
Note générale:	Clinical Trial
	Journal Article
	Multicenter Study
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0923-7534
	info:pmid/12598346